Camlin FineQ4 FY24

Camlin Fine Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹74.28Market Cap: ₹1.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • Blends business expected to grow from Rs. 780 crores (FY24) to over Rs. 1,000 crores in FY25.
  • Vanillin business projected to contribute around Rs. 200 crores in revenue in FY25.
  • Hydroquinone and downstream products expected to add Rs. 600-700 crores revenue.
  • Total conservative revenue outlook for FY25 is Rs. 1,800 - Rs. 1,900 crores, reflecting ~10% growth.
  • Volume growth seen in TBHQ and BHA by 10-15% despite price reductions.
  • North America and Brazil subsidiaries showing strong sales growth and positive EBITDA, likely to continue.
  • Vanillin plant capacity utilization anticipated at 40-50% in FY25, ramping up sale and market share, including targeting 400-500 tons in India.
  • Market demand expected to improve towards end of FY25 with possible price recovery.
  • Repurposing of European and China plants planned to support future growth with CAPEX around $3 million each.

See what Camlin Fine management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
- Camlin Fine Sciences is not currently planning any fresh loans as of the latest earnings call. - Some growth in turnover may require additional working capital, but it is not expected to increase overall debt by the end of next year. - The company plans to repay around Rs. 25 crores of long-term loans over the year. - No mention of any new equity fundraising was made in the call or transcript. - Repurposing projects in Europe and China, involving capex about $2-3 million each, are planned but expected to be funded from internal accruals or existing resources, no new fundraising indicated. Overall, Camlin Fine Sciences expects manageable debt levels with no significant fresh debt or equity raise planned in the near future.

See what Camlin Fine management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The Italy plant is being repurposed to produce MEHQ and Guaiacol, with financial closure pending; project stabilization and commercialization expected by end of FY25 (Page 13-14).
  • Planned capex for repurposing Europe plant is estimated at $2 million to $3 million (Page 6).
  • China plant repurposing investment is around Rs. 25 crores (~$3 million) (Page 6).
  • MEHQ and Guaiacol production in Italy projected to start contributing commercially in FY26 after validation and stabilization in FY25 (Page 13).
  • No new significant loans planned; some working capital may be needed for growth, but overall debt expected to remain stable with Rs. 25 crores of long-term loan repayment planned (Page 14-15).
  • No further major write-offs or unaccounted losses expected; legacy issues accounted for (Page 14-15).

Track Camlin Fine — get its next earnings analysis in your feed

How does Camlin Fine rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisCamlin Fine
Rev 3Mar 3

How does Camlin Fine rank in Chemicals & Petrochemicals?

Compare Camlin Fine against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →